There are 2137 resources available
1500TiP - A phase Ib/II, multicenter, open-label, dose-escalation and dose-expansion study evaluating trastuzumab deruxtecan (T-DXd; DS-8201) monotherapy and combinations in patients with HER2-overexpressing gastric cancer (DESTINY-Gastric03)
Presenter: Yelena Janjigian
Session: E-Poster Display
Resources:
Abstract
1501TiP - Changes in the tumour immune microenvironment in oesophageal squamous cell carcinoma patients receiving different neoadjuvant therapies
Presenter: Wei Li Wang
Session: E-Poster Display
Resources:
Abstract
1502TiP - Paclitaxel + ramucirumab versus paclitaxel alone in patients with squamous-cell carcinoma of the esophagus, refractory or intolerant to combination therapy with fluoropyrimidine and platinum-based drugs - RAMOS, a randomized phase II trial of the German Gastric Group of the AIO
Presenter: Sylvie Lorenzen
Session: E-Poster Display
Resources:
Abstract
1503TiP - A prospective study of apatinib in combination with neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Presenter: Jun Wang
Session: E-Poster Display
Resources:
Abstract
1506P - The predictive value of 2-D myocardial strain for epirubicin-induced cardiotoxicity
Presenter: Ichrak Ben Abdallah
Session: E-Poster Display
Resources:
Abstract
1507P - A retrospective study of angiotensin-converting enzyme inhibitors or beta-blockers to prevent trastuzumab-induced cardiotoxicity
Presenter: Kai Sun
Session: E-Poster Display
Resources:
Abstract
1508P - Safety, efficacy, and patients' satisfaction of initial peripherally inserted central catheters compared with usual intravenous access in terminally ill cancer patients: A randomized phase II study
Presenter: Kwonoh Park
Session: E-Poster Display
Resources:
Abstract
1509P - Impact of differential diagnosis of cachexia and refractory cachexia and appropriate nutritional support for cachexia on survival in terminal cancer patients
Presenter: Nobuhisa Nakajima
Session: E-Poster Display
Resources:
Abstract
1510P - Effects and feasibility of home parenteral nutrition (HPN) in cancer patients with or without migrant background
Presenter: Lena Schickhaus
Session: E-Poster Display
Resources:
Abstract
1511P - A real world study of pyrotinib in patients with HER-2 positive/mutations tumors excluding breast cancer
Presenter: Jun Qian
Session: E-Poster Display
Resources:
Abstract